Simple endoglycosidase-assisted peptide mapping workflow for characterizing non-consensus n-glycosylation in therapeutic monoclonal antibodies
Journal of Pharmaceutical Sciences · 2025
DOI: 10.1016/j.xphs.2024.11.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Sciences, 2025. Verfasst von Jieqiang Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Chemistry, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. Electronic address: jieqiang.zhong@regeneron.com. Hauptthemen laut MEDLINE: Glycoside Hydrolases, Antibodies, Monoclonal, Peptide Mapping. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regeneron Pharmaceuticals.
Abstract (Originalsprache)
N-linked glycosylation, an extensively studied protein post-translational modification, was conventionally understood to occur at asparagine (Asn or N) sites with the consensus motif NXS/T, where X can be any amino acid residue except for proline, followed by serine or threonine. However, with advancements in characterization techniques and bioinformatic tools, increasing evidence indicates that Asn residues that are not located in the NXS/T consensus motif can also undergo N-glycosylation, which is also known as non-consensus or noncanonical N-glycosylation. Characterizing non-consensus N-glycosylation remains challenging because of the unpredictable sequon and its relatively low abundance. Here, we report an endoglycosidase-assisted peptide mapping workflow for mass spectrometry (MS) characterization of non-consensus N-glycosylation in monoclonal antibodies (mAbs). The feasibility of the workflow was demonstrated by a challenging case study, in which an atypical glycosite located within an NPNNXN sequence in a 25-residue tryptic peptide was identified in the fragment antigen-binding (Fab) region of a mAb. With the aids of endoglycosidase treatment, the resulting truncated glycan structures improved peptide ionization efficiency in MS and hence facilitated reliable quantitation of glycosite occupancy. Meanwhile, the remaining mono-/di-saccharides served as a large mass tag enabling differentiation between the glycopeptide and deamidated peptide, thus allowing for database searching for glycosite localization and semi-automation of the data processing workflow. This workflow offers a simple solution for characterizing non-consensus N-glycosylation for the development of therapeutic mAbs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Analytical Chemistry, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. Electronic address: jieqiang.zhong@regeneron.com.
- Analytical Chemistry, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. Electronic address: ming.huang@regeneron.com.
- Analytical Chemistry, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Förderung
- Regeneron Pharmaceuticals
Zitieren
APA
Zhong, J., Huang, M., Qiu, H., Seol, H., Yan, Y., Wang, S., & Li, N. (2025). Simple endoglycosidase-assisted peptide mapping workflow for characterizing non-consensus n-glycosylation in therapeutic monoclonal antibodies. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2024.11.024
Vancouver
Zhong J, Huang M, Qiu H, Seol H, Yan Y, Wang S, et al. Simple endoglycosidase-assisted peptide mapping workflow for characterizing non-consensus n-glycosylation in therapeutic monoclonal antibodies. Journal of Pharmaceutical Sciences. 2025. doi:10.1016/j.xphs.2024.11.024
BibTeX
@article{Zhong2025,
author = {Zhong, Jieqiang and Huang, Ming and Qiu, Haibo and Seol, Haeri and Yan, Yuetian and Wang, Shunhai and Li, Ning},
title = {Simple endoglycosidase-assisted peptide mapping workflow for characterizing non-consensus n-glycosylation in therapeutic monoclonal antibodies},
journal = {Journal of Pharmaceutical Sciences},
year = {2025},
doi = {10.1016/j.xphs.2024.11.024}
}
EUVIMED